---
input_text: 'Antiseizure medication prescribing in people with Dravet syndrome: An
  analysis of real-time administrative data. Since 2018, three new antiseizure medications
  (ASMs) received FDA approval for Dravet syndrome (DS) in the U.S: cannabidiol, stiripentol,
  and fenfluramine. Yet, the uptake of these ASMs in routine clinical practice is
  unknown. We use new ICD-10 codes for DS (implemented in 2020) to estimate ASM receipt
  in patients with DS. We analyzed the TriNetX Network, a real-time electronic health
  record-based dataset linked to prescription data encompassing all 50 states of the
  U.S. After identifying patients with health care encounters for DS in 2021 and 2022
  (via ICD-10 codes), we examined ASM prescribing in the year following a DS claim:
  2022 and 2023, respectively. We retrieved 387 and 451 patients receiving claims
  for DS in 2021 and 2022, respectively. Clobazam, diazepam, valproate, midazolam,
  clonazepam, levetiracetam, and cannabidiol were the most common ASMs used (29%-44%).
  Stiripentol and fenfluramine prescribing was limited (7%-16%); these two ASMs, considered
  second-line therapies in DS, were prescribed less often than ASMs considered third-line
  or beyond. Cannabidiol, stiripentol, and fenfluramine prescribing rates remained
  nearly identical in the 2021 and 2022 cohorts. Our data suggests that stiripentol,
  fenfluramine, and, to an extent, cannabidiol may be underused in a large, diverse,
  primarily U.S.-based population of patients with DS. PLAIN LANGUAGE SUMMARY: In
  an analysis of routinely-collected health care claims in the U.S., we found that
  the uptake of new antiseizure medications for Dravet Syndrome (i.e., stiripentol,
  fenfluramine, and cannabidiol) has been limited since 2022. Even though stiripentol
  and fenfluramine are considered second-line treatments for Dravet syndrome, we found
  they were prescribed less frequently than medicines considered third-line or beyond.
  These findings raise concern for underutilization of new antiseizure medications
  for Dravet syndrome in the United States.'
raw_completion_output: |-
  primary_disease: Dravet syndrome
  medical_actions: prescription of cannabidiol; prescription of stiripentol; prescription of fenfluramine; prescription of clobazam; prescription of diazepam; prescription of valproate; prescription of midazolam; prescription of clonazepam; prescription of levetiracetam
  symptoms: seizures
  chemicals: cannabidiol; stiripentol; fenfluramine; clobazam; diazepam; valproate; midazolam; clonazepam; levetiracetam
  action_annotation_relationships: prescription of cannabidiol TREATS seizures IN Dravet syndrome; prescription of stiripentol TREATS seizures IN Dravet syndrome; prescription of fenfluramine TREATS seizures IN Dravet syndrome; prescription of clobazam TREATS seizures IN Dravet syndrome; prescription of diazepam TREATS seizures IN Dravet syndrome; prescription of valproate TREATS seizures IN Dravet syndrome; prescription of midazolam TREATS seizures IN Dravet syndrome; prescription of clonazepam TREATS seizures IN Dravet syndrome; prescription of levetiracetam TREATS seizures IN Dravet syndrome
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  prescription of levetiracetam TREATS seizures IN Dravet syndrome

  ===

extracted_object:
  primary_disease: MONDO:0100135
  medical_actions:
    - prescription of cannabidiol
    - prescription of stiripentol
    - prescription of fenfluramine
    - prescription of clobazam
    - prescription of diazepam
    - prescription of valproate
    - prescription of midazolam
    - prescription of clonazepam
    - prescription of levetiracetam
  symptoms:
    - HP:0001250
  chemicals:
    - CHEBI:69478
    - CHEBI:228488
    - CHEBI:5000
    - CHEBI:31413
    - CHEBI:49575
    - CHEBI:60654
    - CHEBI:6931
    - CHEBI:3756
    - CHEBI:6437
  action_annotation_relationships:
    - subject: prescription
      predicate: TREATS
      object: HP:0001250
      qualifier: MONDO:0100135
      subject_extension: CHEBI:69478
    - subject: prescription
      predicate: TREATS
      object: HP:0001250
      qualifier: MONDO:0100135
      subject_extension: CHEBI:228488
    - subject: prescription of fenfluramine
      predicate: TREATS
      object: HP:0001250
      qualifier: MONDO:0100135
      subject_extension: CHEBI:5000
    - subject: prescription
      predicate: TREATS
      object: HP:0001250
      qualifier: MONDO:0100135
      subject_extension: CHEBI:31413
    - subject: prescription of diazepam
      predicate: TREATS
      object: HP:0001250
      qualifier: MONDO:0100135
      subject_extension: CHEBI:49575
    - subject: prescription of valproate
      predicate: TREATS
      object: HP:0001250
      qualifier: MONDO:0100135
      subject_extension: CHEBI:60654
    - subject: prescription of midazolam
      predicate: TREATS
      object: HP:0001250
      qualifier: MONDO:0100135
      subject_extension: CHEBI:6931
    - subject: prescription
      predicate: TREATS
      object: HP:0001250
      qualifier: MONDO:0100135
      subject_extension: CHEBI:3756
    - subject: prescription
      predicate: TREATS
      object: HP:0001250
      qualifier: MONDO:0100135
      subject_extension: CHEBI:6437
named_entities:
  - id: MONDO:0100135
    label: Dravet syndrome
  - id: MAXO:0001187
    label: hysteroscopy
  - id: CHEBI:44915
    label: propofol
  - id: CHEBI:119915
    label: fentanyl
  - id: CHEBI:9130
    label: sevoflurane
  - id: HP:0001250
    label: seizures
  - id: CHEBI:6443
    label: Mirena
  - id: MONDO:0002602
    label: Central nervous system diseases
  - id: HP:0002011
    label: central nervous system diseases
  - id: MONDO:0005027
    label: Epilepsy
  - id: HP:0002014
    label: Diarrhea
  - id: HP:0000988
    label: Rash
  - id: CHEBI:228488
    label: Stiripentol
  - id: CHEBI:60654
    label: Valproate
  - id: CHEBI:69478
    label: Cannabidiol
  - id: CHEBI:80634
    label: 2-propyl-4-pentenoic acid (4-ene-VPA)
  - id: HP:0002373
    label: Febrile seizures
  - id: MAXO:0001298
    label: therapy
  - id: CHEBI:31413
    label: clobazam (CLB)
  - id: HP:0010819
    label: drop seizures
  - id: HP:0002329
    label: somnolence
  - id: HP:0004396
    label: decreased appetite
  - id: CHEBI:9925
    label: sodium valproate
  - id: MONDO:0016532
    label: Lennox-Gastaut syndrome
  - id: HP:0000729
    label: Autistic behaviors
  - id: HP:0033258
    label: Sudden unexpected death in epilepsy
  - id: MAXO:0001001
    label: Gene therapy
  - id: MONDO:0002125
    label: Status epilepticus
  - id: HP:0032656
    label: Febrile status epilepticus
  - id: MAXO:0001017
    label: vaccination
  - id: HP:0002069
    label: Generalized tonic-clonic seizure
  - id: CHEBI:3359
    label: CBDA
  - id: CHEBI:167557
    label: CBCA
  - id: CHEBI:66964
    label: Delta9-tetrahydrocannabinol (THC)
  - id: CHEBI:39867
    label: Valproic acid
  - id: CHEBI:5000
    label: Fenfluramine
  - id: HP:0033349
    label: recurrent seizures
  - id: MAXO:0000058
    label: Drug treatment
  - id: HP:0020219
    label: motor seizures
  - id: CHEBI:76720
    label: Antisense oligonucleotides
  - id: MAXO:0001593
    label: ASO therapy
  - id: HP:0012378
    label: Fatigue
  - id: HP:0001945
    label: Pyrexia
  - id: HP:0001654
    label: valvular heart disease
  - id: HP:0002092
    label: pulmonary arterial hypertension
  - id: HP:0002133
    label: Status epilepticus
  - id: CHEBI:17115
    label: vaccine(s)
  - id: MONDO:0100062
    label: Developmental and/or epileptic encephalopathies (DEE)
  - id: HP:0001260
    label: dysarthria
  - id: HP:0001254
    label: lethargy
  - id: HP:0002315
    label: headache
  - id: CHEBI:233158
    label: soticlestat
  - id: CHEBI:34310
    label: 24S-hydroxycholesterol (24HC)
  - id: CHEBI:9586
    label: Tiagabine
  - id: CHEBI:6437
    label: Levetiracetam
  - id: HP:0000708
    label: behavioral problems
  - id: CHEBI:16113
    label: Cholesterol
  - id: MAXO:0001394
    label: Oral administration
  - id: CHEBI:173124
    label: 2-linoleoyl glycerol (2-LG)
  - id: CHEBI:52392
    label: 2-AG
  - id: CHEBI:2700
    label: anandamide
  - id: CHEBI:52640
    label: N-acylethanolamines
  - id: CHEBI:35623
    label: Anticonvulsants
  - id: MAXO:0000942
    label: Vagus nerve stimulation (VNS)
  - id: HP:0002360
    label: Sleep disturbance
  - id: HP:0001249
    label: Intellectual disability
  - id: HP:0001251
    label: ataxia
  - id: CHEBI:42638
    label: fenfluramine (FFA)
  - id: HP:0032794
    label: Myoclonic seizures
  - id: CHEBI:190616
    label: N-desmethylclobazam
  - id: MONDO:0013801
    label: SCN8A encephalopathy
  - id: HP:0001263
    label: Developmental delay
  - id: HP:0100543
    label: Cognitive impairment
  - id: CHEBI:35493
    label: antipyretics
  - id: MAXO:0000932
    label: Electroencephalography (EEG)
  - id: HP:0002353
    label: EEG abnormalities
  - id: CHEBI:73601
    label: <Ketogenic diet (KD)>
  - id: CHEBI:49575
    label: diazepam
  - id: CHEBI:6931
    label: midazolam
  - id: CHEBI:3756
    label: clonazepam
